BE893193A - Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif - Google Patents

Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif

Info

Publication number
BE893193A
BE893193A BE0/208097A BE208097A BE893193A BE 893193 A BE893193 A BE 893193A BE 0/208097 A BE0/208097 A BE 0/208097A BE 208097 A BE208097 A BE 208097A BE 893193 A BE893193 A BE 893193A
Authority
BE
Belgium
Prior art keywords
cholecalciferol
dihydroxy
pharmaceutical composition
active ingredient
composition containing
Prior art date
Application number
BE0/208097A
Other languages
English (en)
Original Assignee
Kureha Chemical Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP7326481A external-priority patent/JPS57188520A/ja
Priority claimed from JP19801681A external-priority patent/JPS58109421A/ja
Priority claimed from JP19801581A external-priority patent/JPS58109422A/ja
Priority claimed from JP1860082A external-priority patent/JPS58135812A/ja
Priority claimed from JP6286882A external-priority patent/JPS58185519A/ja
Priority claimed from JP6568982A external-priority patent/JPS58185520A/ja
Priority claimed from JP7068282A external-priority patent/JPS58188816A/ja
Application filed by Kureha Chemical Ind Co Ltd filed Critical Kureha Chemical Ind Co Ltd
Publication of BE893193A publication Critical patent/BE893193A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE0/208097A 1981-05-15 1982-05-14 Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif BE893193A (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP7326481A JPS57188520A (en) 1981-05-15 1981-05-15 Antihyperkalemia
JP19801681A JPS58109421A (ja) 1981-12-09 1981-12-09 免疫機能低下防止剤
JP19801581A JPS58109422A (ja) 1981-12-09 1981-12-09 抗潰瘍剤
JP1860082A JPS58135812A (ja) 1982-02-08 1982-02-08 マグネシウム代謝調節剤
JP6286882A JPS58185519A (ja) 1982-04-15 1982-04-15 抗高燐血症剤
JP6568982A JPS58185520A (ja) 1982-04-20 1982-04-20 血糖調節剤
JP7068282A JPS58188816A (ja) 1982-04-27 1982-04-27 抗腫瘍剤

Publications (1)

Publication Number Publication Date
BE893193A true BE893193A (fr) 1982-11-16

Family

ID=27563835

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/208097A BE893193A (fr) 1981-05-15 1982-05-14 Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif

Country Status (3)

Country Link
US (1) US4442093A (fr)
BE (1) BE893193A (fr)
IT (1) IT1190824B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1272953A (fr) * 1984-10-08 1990-08-21 Yuji Makino Compose pharmaceutique pour usage externe contenant de la vitasmine d.sub.3 de type acitf
US4866048A (en) * 1985-08-02 1989-09-12 Leo Pharmaceutical Products Ltd. Novel vitamin D analogues
IL77668A (en) * 1986-01-21 1989-03-31 Teva Pharma Production of cholecalciferol derivatives and novel intermediates used therefor
US4677075A (en) * 1986-05-05 1987-06-30 Louderback Allan Lee Urobilinogen control
JPS6391323A (ja) * 1986-10-03 1988-04-22 Kureha Chem Ind Co Ltd 抗尿路結石症剤
US5001118A (en) * 1986-12-29 1991-03-19 Kureha Kagaku Kogyo Kabushiki Kaisha Method for preventing senescence and increasing bone mass
US4997824A (en) * 1987-07-22 1991-03-05 Teva Pharmaceutical Industries Ltd. Combination of cholecalciferol derivatives for the treatment of renal bone disease
US5393742A (en) * 1990-08-30 1995-02-28 Mect Corporation Preparation for treating renal disease
US6291444B1 (en) * 1993-06-16 2001-09-18 Wisconsin Alumni Research Foundation Treatment of t-cell immunodeficiencies with vitamin D compounds
US7129230B2 (en) 2001-03-12 2006-10-31 Nestec S.A. Method and product for treating cancer in pets
ES2593047T3 (es) 2006-02-03 2016-12-05 Opko Renal, Llc Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3
CA2655499C (fr) 2006-06-21 2015-10-27 Proventiv Therapeutics, Llc Methode de traitement et de prevention de l'hyperparathyroidie secondaire au moyen de therapies de repletion de vitamine d et de remplacement devitamine d
HUE063590T2 (hu) 2007-04-25 2024-01-28 Eirgen Pharma Ltd Szabályozott felszabadulású 25-hidroxi-D-vitamin
PT2148684E (pt) 2007-04-25 2013-04-19 Cytochroma Inc Método de tratamento para a insuficiência e deficiência de vitamina d
US8198245B2 (en) * 2007-07-27 2012-06-12 Humacyte, Inc. Compositions and methods for soft tissue augmentation
US20090048160A1 (en) * 2007-08-17 2009-02-19 Bannerman Douglas D Antimicrobial activity of bovine bactericidal/permeability-increasing protein (BPI)-derived peptides against Gram-negative bacterial mastitis isolates
EP2432495B1 (fr) * 2009-05-20 2017-03-22 Humacyte, Inc. Elastine pour l'augmentation des tissus mous
CA2797537C (fr) 2010-03-29 2021-11-23 Cytochroma Inc. Utilisation du compose de 25-hydroxyvitamine d pour la reduction des niveaux de la parathyroide
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
KR20170047265A (ko) 2014-08-07 2017-05-04 옵코 아일랜드 글로벌 홀딩스 리미티드 25-하이드록시비타민 d를 이용한 보조요법
KR20230056790A (ko) 2016-03-28 2023-04-27 옵코 아일랜드 글로벌 홀딩스 리미티드 비타민 d 치료 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3715374A (en) * 1972-05-05 1973-02-06 Wisconsin Alumni Res Found 24,25-dihydroxycholecalciferol
US3994878A (en) * 1975-10-10 1976-11-30 Hoffmann-La Roche Inc. Syntheses of 24R,25- and 24S,25-dihydroxycholesterol and alkanoyl derivatives thereof
JPS55136229A (en) * 1979-04-10 1980-10-23 Teijin Ltd Adjustment of bone metabolism in warm-blooded animal and drug for it

Also Published As

Publication number Publication date
IT8221278A0 (it) 1982-05-14
IT1190824B (it) 1988-02-24
US4442093A (en) 1984-04-10

Similar Documents

Publication Publication Date Title
BE893193A (fr) Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
FR2602141B1 (fr) Composition pharmaceutique a activite analgesique contenant de l'ibuprofene comme principe actif
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
FR2526271B1 (fr) Composition herbicide contenant un derive de 1, 2, 4-triazole a titre d'ingredient actif
FR2510888B1 (fr) Nouvelles compositions a usage pharmaceutique a effet prolonge de liberation d'un ingredient actif
FR2527597B1 (fr) Derives d'alcool b,g-dihydropolyprenylique et composition pharmaceutique contenant un compose polyprenylique
FR2569694B1 (fr) Derives d'ethylenediaminemonoamide, composition pharmaceutique les contenant et utilisation de ces composes a titre d'antidepresseur ou d'antiparkinsonien
FR2567510B1 (fr) Composes d'aminophenol et compositions pharmaceutiques les contenant
BE879472A (fr) Composition pharmaceutique contenant des 3,4-dihydro-3-oxo-2-quinoxalines
FR2490491B1 (fr) Composition pharmaceutique analgesique contenant comme ingredient actif l'acide 3-amino-2-hydroxy-4 phenylbutanoique et ses derives et application
BE861888A (fr) Compositions contenant un derive de l'acide salicyclique et applications a titre de medicament
FR2556218B1 (fr) Produit pharmaceutique pour application locale constitue par l'association d'un principe actif medicamenteux-agent enzymatique
FR2515038B1 (fr) A titre de medicaments, certains derives de l'acide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant
FR2540498B1 (fr) Nouveaux medicaments derives d'amides d'acide mercaptoacetique et de l'acide 3-mercaptopropionique et les compositions pharmaceutiques les renfermant
FR2585953B1 (fr) Composition pharmaceutique pour l'administration orale contenant de l'ubiquinone et procede
IT1191651B (it) Composti acilamminoalcanoilici ad attivita' farmaceutica
FR2614788B1 (fr) Composition pharmaceutique a activite antiseptique
FR2505824B1 (fr) Derives d'isoprenylamine et leur application a des compositions pharmaceutiques
IT8123546A0 (it) Composto ad attivita' antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative
FR2556592B1 (fr) Compositions pharmaceutiques contenant des derives de l'acide campho-methylidene cinnamique
BE892911A (fr) Nitroimidazoles a activite trichomonacide, leur preparation et compositions pharmaceutiques en contenant
FR2607005B1 (fr) Compositions pharmaceutiques contenant de l'acide ursodesoxycholique
FR2483918B1 (fr) Composition anti-inflammatoire contenant a titre de principe actif des derives de l'acide phenyl-acetique ou phenyl-propionique
FR2652086B1 (fr) Compose nouveau d'origine vegetale, derive de l'acide cafeique, l'oraposide; composition a usage therapeutique et composition dermato-cosmetique le contenant.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: KUREHA KAGAKU KOGYO K.K.

Effective date: 19980531